Seeing Is Believing
Healthcare - Sector
Galera Therapeutics's activity chart (see below) currently has 20 price targets and 35 ratings on display.
Analysts average stock forecasts to be materialized ratio is 78.33% with an average time for these price targets to be met of 948.5 days.
Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 29-Aug-2023. First documented stock forecast 02-Dec-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 29-Aug-2023
$0.25
$-16.03 (-98.46%)
3 years 17 days ago
(29-Aug-2023)
1/5 (20%)
$0.04 (19.05%)
50
Buy Since 16-Dec-2021
$0.3
$-15.98 (-98.16%)
$6
3 years 30 days ago
(16-Aug-2023)
4/4 (100%)
$0.05 (20.00%)
1352
Buy Since 21-Feb-2023
$0.5
$-15.78 (-96.93%)
$6
3 years 1 months 5 days ago
(10-Aug-2023)
2/2 (100%)
$0.14 (38.89%)
1153
Buy Since 02-Dec-2019
$7
$-9.28 (-57.00%)
3 years 6 months 30 days ago
(16-Feb-2023)
3/3 (100%)
$5.41 (340.25%)
430
Hold Since 14-Dec-2021
$15
4 years 8 months 30 days ago
(16-Dec-2021)
1/2 (50%)
$12.3 (455.56%)
1672
What is GRTX (Galera Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on GRTX (Galera Therapeutics)?
Which analyst has the current lower performing score on GRTX (Galera Therapeutics) with a proven track record?
Which analyst has the most public recommendations on GRTX (Galera Therapeutics)?
Which analyst is the currently most bullish on GRTX (Galera Therapeutics)?
Which analyst is the currently most reserved on GRTX (Galera Therapeutics)?